Skip to content

Clinical trials

Phase 3 Urinary Bladder, Overactive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Phase: Phase 3 Country / region: United States Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20045
20051
20065
20076
20086
20095
20103
20123
20134
20141
20161
20183
20192
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated6
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan8
Astellas Pharma Inc6
Astellas Pharma Europe B.V.4
Pfizer4
Urovant Sciences GmbH4
Duramed Research2
Novartis2
Astellas Pharma Europe Ltd.1
Bayer1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive47
Urinary Incontinence15
Urinary Incontinence, Urge9
Lower Urinary Tract Symptoms3
Nocturia3
Urologic Diseases3
Prostatic Hyperplasia2
Hereditary Sensory and Autonomic Neuropathies1
Parkinson Disease1
Spinal Cord Injuries1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.